Literature DB >> 17439674

Cerebral cortical dysfunction in chronic obstructive pulmonary disease: role of transcranial magnetic stimulation.

A A R Mohamed-Hussein1, S A Hamed, N Abdel-Hakim.   

Abstract

SETTING: Chest and Neurology Departments, Assiut and Al-Azhar University Hospitals, Egypt.
OBJECTIVES: To study a large population with respect to previous preliminary data, using transcranial magnetic stimulation (TMS) as a prognostic method for evaluation of cerebral cortical functions during acute exacerbation of chronic obstructive pulmonary disease (AE-COPD).
DESIGN: In a case-control study, 41 patients with AE-COPD and 30 healthy controls were included. For all, TMS was used to assess corticospinal pathway function and cortical excitability.
RESULTS: Patients demonstrated increased motor threshold (resting and active), central motor conduction time and increased cortical silent period. Significant correlation was identified between TMS parameters and pulmonary function tests (forced vital capacity, forced expiratory volume 1%, forced expiratory volume in one second) and arterial blood gases (pH, paO(2) and HCO(3)), serum chloride and potassium.
CONCLUSION: These results indicate that the motor cortex is less excitable during AE-COPD. This is attributed to reduction of cortical excitability due to chronic hypoxaemia. Therefore, early detection of cerebral changes might be in accordance with the importance of early O(2) therapy in reducing morbidity and mechanical ventilation dependency in COPD. This opens discussion for future early therapeutic use of GABAergic and glutaminergic modulating drugs with oxygen to protect the brains of COPD patients.

Entities:  

Mesh:

Year:  2007        PMID: 17439674

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  6 in total

1.  Functional involvement of central nervous system at high altitude.

Authors:  Giacinta Miscio; Eva Milano; Juan Aguilar; Giulio Savia; Guglielmo Foffani; Alessandro Mauro; Laura Mordillo-Mateos; Javier Romero-Ganuza; Antonio Oliviero
Journal:  Exp Brain Res       Date:  2009-02-17       Impact factor: 1.972

Review 2.  An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.

Authors:  François Maltais; Marc Decramer; Richard Casaburi; Esther Barreiro; Yan Burelle; Richard Debigaré; P N Richard Dekhuijzen; Frits Franssen; Ghislaine Gayan-Ramirez; Joaquim Gea; Harry R Gosker; Rik Gosselink; Maurice Hayot; Sabah N A Hussain; Wim Janssens; Micheal I Polkey; Josep Roca; Didier Saey; Annemie M W J Schols; Martijn A Spruit; Michael Steiner; Tanja Taivassalo; Thierry Troosters; Ioannis Vogiatzis; Peter D Wagner
Journal:  Am J Respir Crit Care Med       Date:  2014-05-01       Impact factor: 21.405

3.  Diaphragmatic motor cortex hyperexcitability in patients with chronic obstructive pulmonary disease.

Authors:  Rehab Elnemr; Rania Ahmad Sweed; Hanaa Shafiek
Journal:  PLoS One       Date:  2019-12-18       Impact factor: 3.240

4.  Ascorbate attenuates cycling exercise-induced neuromuscular fatigue but fails to improve exertional dyspnea and exercise tolerance in COPD.

Authors:  Thomas J Hureau; Joshua C Weavil; Simranjit K Sidhu; Taylor S Thurston; Van R Reese; Jia Zhao; Ashley D Nelson; Nathaniel M Birgenheier; Russell S Richardson; Markus Amann
Journal:  J Appl Physiol (1985)       Date:  2020-11-05

5.  Respiratory electrophysiologic studies in chronic obstructive pulmonary disease.

Authors:  Yu Wang; Na Liu; Zhecheng Zhang
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.889

6.  Specific motor cortex hypoexcitability and hypoactivation in COPD patients with peripheral muscle weakness.

Authors:  Francois Alexandre; Nelly Héraud; Emilie Tremey; Nicolas Oliver; Dominique Bourgouin; Alain Varray
Journal:  BMC Pulm Med       Date:  2020-01-03       Impact factor: 3.317

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.